Circle Pharma: Funding, Investors & Team (Sep 2026)
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational design algorithms and creative chemistry to create macrocycle peptide treatments that can penetrate cells and target key diseases. Their approach involves a systematic design process using virtual libraries of diverse macrocycle scaffolds chosen for their permeability. Established by Matt Jacobson and Scott Lokey in 2012, the company is led by David J. Earp.
Circle Pharma has raised $210M across 3 funding rounds on record, the most recent a Series D of $90.0M announced in Sep 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Circle Pharma Company Profile and Key Stats
Latest funding round on record: Sep 2024.
Circle Pharma Funding Rounds
Circle Pharma raised $66.0M in an undisclosed round announced in Jun 2021.
3.1 years later, a Series D of $54.2M was announced in Jul 2024.
2 months later, a Series D of $90.0M was announced in Sep 2024.
Circle Pharma Founders and Leadership Team
No contact details are on record for this team yet.
Circle Pharma Funding Compared to Other Biotechnology Startups
Circle Pharma's latest round of $90.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Circle Pharma in Biotechnology and San Francisco
Companies Similar to Circle Pharma
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Circle Pharma Funding FAQs
What does Circle Pharma do?
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational design algorithms and creative chemistry to create macrocycle peptide treatments that can penetrate cells and target key diseases. Their approach involves a systematic design process using virtual libraries of diverse macrocycle scaffolds chosen for their permeability. Established by Matt Jacobson and Scott Lokey in 2012, the company is led by David J. Earp.
How much funding has Circle Pharma raised?
Circle Pharma has raised $210M across 3 rounds on record. The most recent is a Series D of $90.0M announced in Sep 2024.
When did Circle Pharma last raise funding?
Circle Pharma's most recent funding round on record is a Series D of $90.0M, announced in Sep 2024.
Who founded Circle Pharma?
FundedIQ lists Scott Lokey (Founder) at Circle Pharma.
Who is the CEO of Circle Pharma?
David Earp is listed as CEO at Circle Pharma.
Where is Circle Pharma headquartered?
Circle Pharma is based in San Francisco, California, United States.
How many employees does Circle Pharma have?
Circle Pharma is in the 11-50 employee band.
How does Circle Pharma's funding compare to other Biotechnology startups?
Circle Pharma's latest round of $90.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Circle Pharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Circle Pharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.